UTHR UNITED THERAPEUTICS PE ratio, current and historical analysis
As at Nov 21, 2024, the UTHR stock has a PE ratio of 15.11. This is based on the current EPS of $24.31 and the stock price of $367.36 per share. An increase of 23% has been seen in the P/E ratio compared to the average of 12.3 of the last 4 quarters.
UTHR PE ratio history
The mean historical PE ratio of UNITED THERAPEUTICS over the last ten years is 13.97. The current 15.11 PE ratio is 8% above the historical average. Over the past ten years, UTHR's PE ratio was at its highest in the Jun 2015 quarter at 47.14, with a price of $173.95 and an EPS of $3.69. The Jun 2016 quarter recorded the bottom point at 4.74, with a price of $105.92 and an EPS of $22.35.
UNITED THERAPEUTICS PE ratio by year
Maximum annual increase: 76.93% in 2017
Maximum annual decrease: -48.36% in 2018
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 10.45 | -39.94% |
| 2022 | 17.4 | -14.62% |
| 2021 | 20.38 | 56.41% |
| 2020 | 13.03 | N/A |
| 2019 | N/A | N/A |
| 2018 | 8.04 | -48.36% |
| 2017 | 15.57 | 76.93% |
| 2016 | 8.8 | -20.36% |
| 2015 | 11.05 | -39.75% |
| 2014 | 18.34 | -43.4% |
UTHR average PE ratio chart
Currently, UTHR's PE ratio is greater than its 3, 5 and 10-year historical averages.
UTHR PE vs peers
UTHR's PE ratio is lower than its peer stocks LLY and PFE.
| Stock name | PE ratio | Market cap |
|---|---|---|
| UTHR UNITED THERAPEUTICS Corp | 15.11 | $16.4B |
| CAH Cardinal Health Inc | 23.83 | $29.87B |
| PFE Pfizer Inc | 33.07 | $142.41B |
| LLY ELI LILLY & Co | 80.72 | $711.91B |
| BAX Baxter International Inc | 157.1 | $16.84B |
| GILD Gilead Sciences Inc | 897.6 | $111.86B |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $19.35B |
| CYTK Cytokinetics Inc | N/A | $5.63B |
Frequently asked questions
What is UNITED THERAPEUTICS's PE ratio?
As of Nov 21, 2024, UTHR stock has a price to earnings ratio of 15.11.
What is the 3-year average PE ratio for UNITED THERAPEUTICS (UTHR)?
The 3-year average PE ratio for UTHR stock is 13.89.
What is the 5-year average PE ratio for UNITED THERAPEUTICS (UTHR)?
The 5-year average PE ratio for UTHR stock is 13.82.
What is the highest PE ratio for UTHR?
Over the last ten years, the quarterly PE ratio reached a historic high of 47.14 in the Jun 2015 quarter.
How does the current PE ratio for UTHR compare to its historical average?
UTHR's current price to earnings ratio is 8% above its 10-year historical average.
How is UTHR's PE ratio calculated (UNITED THERAPEUTICS PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Nov 21, 2024), UNITED THERAPEUTICS's stock price is $367.36. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $24.31. Therefore, UNITED THERAPEUTICS's P/E ratio for today is 15.11. PE RATIO(15.11) = STOCK PRICE($367.36) / TTM EPS($24.31)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.